Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001140361-26-002376·Armata Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Armata Pharmaceuticals, Inc.
Common Stock, $0.01 par value · CUSIP: 04216R102
Event date: 2026-01-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Innoviva, Inc.Reported CIK 0001080014
Shares: 55,467,459.00 · Class: 83.1%
- Innoviva Strategic Opportunities LLCReported CIK 0001842875
Shares: 46,756,659.00 · Class: 70.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-26-002376
- Form type
- SCHEDULE 13D/A
- Filer
- Armata Pharmaceuticals, Inc.
- CIK
- CIK 921114
- Filed
- Jan 26, 2026
- Reporting period
- Jan 23, 2026
- Description
- Schedule 13D beneficial ownership